Revenue: The sum of all revenue fields included for a company's operating activities.
Cardiol Therapeutics Inc. (CRDL) Revenue data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
-- |
$-7.89M |
|
-- |
|
-- |
|
$7.08M |
|
$-7.08M |
|
$-0.81M |
|
$-7.89M |
|
$-7.89M |
|
$-7.89M |
|
$-7.89M |
|
$-7.89M |
|
$-7.89M |
|
$-7.08M |
|
$-7.06M |
|
108.99M |
|
108.99M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$22.79M |
|
$0.10M |
|
$0.10M |
|
$22.89M |
|
$5.19M |
|
$0.06M |
|
$0.06M |
|
$5.25M |
|
$17.64M |
|
$17.64M |
|
$17.64M |
|
111.87M |
|
| Cash Flow Statement Financials | |
$-5.48M |
|
$-0.03M |
|
$9.91M |
|
$15.61M |
|
$20.17M |
|
$4.56M |
|
$1.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.39 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.51M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-44.70% |
|
-44.70% |
|
-34.45% |
|
-44.56% |
|
$0.16 |
|
$-0.05 |
|
$-0.05 |
|